Moving is never just about boxes. When you live with a chronic illness like IgG4-related disease, moving becomes a full‑body experience: physical, emotional, logistical, and deeply personal. I’ve moved more times than I can count: across four countries growing up, across cities while at university, and then again when…
Discussion
Glucocorticoid therapy alone is often not enough to manage rare cases of IgG4-related disease (IgG4-RD) that manifest with thickening of the membrane around the brain and recurrent blood clots blocking the brain’s blood vessels, according to a team of researchers in China who detailed the treatment of an older…
Discussion
The investigational antibody therapy obexelimab lowered disease activity and reduced the need for glucocorticoid rescue therapy among people with immunoglobulin G4-related disease (IgG4-RD), according to final published data from a global clinical trial. The Phase 3 study, called INDIGO (NCT05662241), is the largest ever conducted in IgG4-RD,…
Get regular updates to your inbox.
